team had planned to begin distributing boosters next week, but even if this fda panel signs off, another approval must come from the cdc. president biden s chief medical advisor, dr. anthony fauci, today suggesting approval is likely. the data that i have seen, i believe strongly suggests that will be the case. our position about at least planning for the eadventureuation that we might have to give boosters, we vernal have planned very ready to go, pending the decision that s made from a regulatory standpoint. cnn s senior medical correspondent, elizabeth cohen is here to explain the arguments for or against boosters, so elizabeth, what are you learning from the meeting today? alisyn, this issue is so hotly contested, because the data just doesn t agree with each other. let s first look at the argument against boosters. this argument basically says the two shots, the two shots that so many of us have had, they are